Integrated adoption strategy drove successful conversion with 95 percent member utilization. SALT LAKE CITY, UT— Regence health plans are leading the nation in biosimilars utilization with 95 percent adoption, reducing specialty drug spend by $37 million annually. Biologics are specialty drugs that represent some of the most expensive treatments in the U.S., with annual [...]